WallStreetZen

NYSE: ABT
Abbott Laboratories Stock

$120.90+1.12 (0.94%)
Updated Apr 9, 2021
ABT Price
$120.90
Fair Value Price
N/A
Market Cap
$214.28B
52 Week Low
$83.52
52 Week High
$128.54
P/E
47.98x
P/B
6.49x
P/S
5.61x
PEG
1.49x
Dividend Yield
1.19%
Revenue
$34.61B
Earnings
$4.50B
Gross Margin
56.6%
Operating Margin
16%
Profit Margin
13%
Debt to Equity
1.2
Operating Cash Flow
$8B
Beta
0.91
Next Earnings
Apr 14, 2021
Ex-Dividend
Apr 14, 2021
Next Dividend
May 17, 2021

Zen Score

High
Medium
Low
44
Industry average

Reasons for this score

ABT ($120.90) is trading below its intrinsic value of $293.12, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
ABT is poor value based on its earnings relative to its share price (47.98x), compared to the US market average (18.56x)
Valuation
ABT is poor value based on its earnings relative to its share price (47.98x), compared to the US Medical Devices industry average (43.26x)
Valuation

1 of 13

ABT News

Valuation

ABT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
47.98x
Industry
43.26x
Market
18.56x
ABT is poor value based on its earnings relative to its share price (47.98x), compared to the US market average (18.56x)
Valuation
ABT is poor value based on its earnings relative to its share price (47.98x), compared to the US Medical Devices industry average (43.26x)
Valuation

ABT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.49x
Industry
5.14x
Market
-0.01x
ABT is good value based on its book value relative to its share price (6.49x), compared to the US market average (-0.01x)
Valuation
ABT is poor value based on its book value relative to its share price (6.49x), compared to the US Medical Devices industry average (5.14x)
Valuation

ABT price to earnings growth (PEG)

For valuing profitable companies with growth potential
ABT is poor value relative to its rate of earnings growth, measured by PEG ratio (1.49x)
Valuation

ABT's financial health

Profit margin

Revenue
$10.7B
Net Income
$2.2B
Profit Margin
20.2%
ABT's Earnings (EBIT) of $5.54B can safely cover interest payments on company debt ($18.75B)
Financials
ABT's profit margin has increased (+1.4%) in the last year from (11.6%) to (13%)
Financials

Assets to liabilities

Assets
$72.5B
Liabilities
$39.5B
Debt to equity
0.57
ABT's short-term assets ($20.44B) exceed its short-term liabilities ($11.91B)
Financials
ABT's long-term liabilities ($27.64B) exceed its short-term assets ($20.44B)
Financials
ABT's debt has increased relative to shareholder equity (1.2), over the past 5 years ago (0.93)
Financials
ABT's debt to equity ratio (1.2) is considered high
Financials

Cash flow

Operating
$3.8B
Investing
-$731.0M
Financing
-$787.0M
ABT's operating cash flow ($7.90B) is sufficient to service the company's debt ($18.75B)
Financials

Abbott Laboratories Stock FAQ

What is Abbott Laboratories's quote symbol?

(NYSE: ABT) Abbott Laboratories trades on the NYSE under the ticker symbol ABT. Abbott Laboratories stock quotes can also be displayed as NYSE: ABT.

What is the 52 week high and low for Abbott Laboratories (NYSE: ABT)?

(NYSE: ABT) Abbott Laboratories's 52-week high was $128.54, and its 52-week low was $83.52. It is currently -5.94% from its 52-week high and 44.76% from its 52-week low.

How much is Abbott Laboratories stock worth today?

(NYSE: ABT) Abbott Laboratories currently has 1,772,361,581 outstanding shares. With Abbott Laboratories stock trading at $120.90 per share, the total value of Abbott Laboratories stock (market capitalization) is $214.28B.

Abbott Laboratories stock was originally listed at a price of $32.75 in Dec 31, 1997. If you had invested in Abbott Laboratories stock at $32.75, your return over the last 23 years would have been 269.16%, for an annualized return of 5.84%.

How much is Abbott Laboratories's stock price per share?

(NYSE: ABT) Abbott Laboratories stock price per share is $120.90 today (as of Apr 9, 2021).

What is Abbott Laboratories's Market Cap?

(NYSE: ABT) Abbott Laboratories's market cap is $214.28B, as of Apr 12, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Abbott Laboratories's market cap is calculated by multiplying ABT's current stock price of $120.90 by ABT's total outstanding shares of 1,772,361,581.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.